110
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Is there any effect of oocyte count retrieved in the OPU procedure on pregnancy outcomes?

, , , &

References

  • Beckers NG, Macklon NS, Eijkemans MJ, Fauser BC. 2002. Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertility and Sterility 78:291–297.
  • Bhasin S, de Kretser DM, Baker HW. 1994. Clinical review 64: Pathophysiology and natural history of male infertility. The Journal of Clinical Endocrinology & Metabolism 79:1525–1529.
  • Cai Q, Wan F, Huang K, Zhang H. 2013. Does the number of oocytes retrieved influence pregnancy after fresh embryo transfer? PLoS One 8:e56189.
  • Fatemi HM, Doody K, Griesinger G, Witjies H. 2013. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Human Reproduction 28:442–452.
  • Ferraretti AP, Goossens V, Kupka M, Bhattacharya S, de Mouzon J, Castilla JA, et al.; European 2013. IVF-Monitoring (EIM) Consortium for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Human Reproduction 28:2318–2331.
  • Heijnen EM, Eijkemans MJ, De KC, Polinder S, Beckers NG, Klinkert ER, et al. 2007. A mild treatment strategy for in-vitro fertilisation: a randomized non-inferiority trial. Lancet 369:743–749.
  • Hohmann FP, Macklon NS, Fauser BC. 2003. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. The Journal of Clinical Endocrinology & Metabolism 88:166–173.
  • Ji J, Liu Y, Tong XH, Luo L, Ma J, Chen Z. 2013. The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China. Human Reproduction 28:2728–2734.
  • Joo BS, Park SH, An BM, Kim KS, Moon SE, Moon HS. 2010. Serum oestradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentrationdependent manner. Fertility and Sterility 93:442–446.
  • Kably Ambe A, Estevez Gonzalez S, Carballo Mondragon E, Duran Monterrosas L. 2008. Comparative analysis of pregnancy rate/captured oocytes in an in vitro fertilization program. Ginecología y Obstetricia de México 76:256–260. Spanish.
  • Mitwally MF, Bhakoo HS, Crickard K, Sullivan MW, Batt RE, Yeh J. 2006. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer. Fertility and Sterility 86:588–596.
  • Mosher WD. 1985. Reproductive impairments in the United States, 1965–1982. Demography 22:415–430.
  • Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. 2006. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin releasing hormone antagonist in vitro fertilization cycles. Fertility and Sterility 85:112–120.
  • Pinborg A, Henningsen AK, Malchau SS, Loft A. 2013. Congenital anomalies after assisted reproductive technology. Fertility and Sterility 99:327–332.
  • Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, et al. 2014. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertility and Sterility 101:967–973.
  • Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. 2011. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Human Reproduction 26:1768–1774.
  • Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. 2003. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reproduction Update 9:61–76.
  • Templeton A, Morris JK, Parslow W. 1996. Factors that affect outcome of in-vitro fertilization treatment. Lancet 348:1402–1406.
  • Timeva T, Milachich T, Antonova I, Arabaji T, Shterev A, Omar HA. 2006. Correlation between number of retrieved oocytes and pregnancy rate afetr in vitro fertilization/intracytoplasmic sperm injection. Scientific World Journal 6:686–690.
  • Valbuena D, Martin J, de Pablo JL, Remohi J, Pellicer A, Simon C. 2001. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertility and Sterility 76:962–968.
  • van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE, et al. 2006. Optimum number of oocytes for a successful first IVF treatment cycle. Reproductive BioMedicine Online 13:476–480.
  • Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Baart EB, Hohmann FP, et al. 2009. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Human Reproduction Update 15:5–12.
  • Yoldemir T, Fraser IS. 2010. The effect of retrieved oocyte count on pregnancy outcomes in an assisted reproduction program. Archives of Gynecology and Obstetrics 281:551–556.
  • Younglai EV, Holloway AC, Foster WG. 2005. Environmental and occupational factors affecting fertility and IVF success. Human Reproduction Update 11:43–57.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.